
NNK
CAS No. 64091-91-4
NNK( Nicotine-derived nitrosamine ketone )
Catalog No. M24655 CAS No. 64091-91-4
NNK is a procarcinogen and a major tobacco-specific toxicant. It inhibits the expression of lysyl oxidase which is a tumor suppressor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 50 | In Stock |
![]() ![]() |
10MG | 87 | In Stock |
![]() ![]() |
25MG | 146 | In Stock |
![]() ![]() |
50MG | 215 | In Stock |
![]() ![]() |
100MG | 260 | In Stock |
![]() ![]() |
200MG | 385 | In Stock |
![]() ![]() |
500MG | 617 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameNNK
-
NoteResearch use only, not for human use.
-
Brief DescriptionNNK is a procarcinogen and a major tobacco-specific toxicant. It inhibits the expression of lysyl oxidase which is a tumor suppressor.
-
DescriptionNNK is a procarcinogen and a major tobacco-specific toxicant. It inhibits the expression of lysyl oxidase which is a tumor suppressor.
-
In VitroNNK (100 pM; 0-60 min) stimulates activation of PKCα and MAPKs ERK1/2 that directly induce c-Myc phosphorylation.NNK (100 pM; 96 hours) enhances proliferation of cells expressing WT but not AA c-Myc mutant. Western Blot Analysis Cell Line:NCI-H82 cells Concentration:100 pM Incubation Time:0-60 min Result:Stimulated activation of PKCα and MAPKs ERK1/2 that directly induced c-Myc phosphorylation.Apoptosis Analysis Cell Line:H1299 lung cancer cells Concentration:100 pM Incubation Time:96 hours Result:Enhanced proliferation of cells expressing WT but not T58A/S62A c-Myc mutant.
-
In Vivo——
-
SynonymsNicotine-derived nitrosamine ketone
-
PathwayImmunology/Inflammation
-
TargetLipoxygenase
-
RecptorLOX
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number64091-91-4
-
Formula Weight207.23
-
Molecular FormulaC10H13N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESCN(CCCC(c1cnccc1)=O)N=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cheng G, Li J, Zheng M, Zhao Y, Zhou J, Li W. NNK, a tobacco-specific carcinogen, inhibits the expression of lysyl oxidase, a tumor suppressor. Int J Environ Res Public Health. 2014 Dec 23;12(1):64-82.
molnova catalog



related products
-
ER-34122
ER-34122, a novel orally available dual 5-lipoxygenase/cyclooxygenase inhibitor, exhibits potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
-
NNK
NNK is a procarcinogen and a major tobacco-specific toxicant. It inhibits the expression of lysyl oxidase which is a tumor suppressor.
-
Butibufen
Butibufen (FF-106) is an orally active non-steroidal anti-inflammatory compound, a potential cyclooxygenase inhibitor with analgesic and antipyretic activity, and inhibits urea synthesis.Butibufen has been used in the study of rheumatic diseases.